Boston mRNA startup raises millions to test its targeted cancer therapies

Published: Monday, November 28, 2022 at 3:35 pm

The $97 million in new money comes as anticipation builds for companies to prove that the COVID-19 vaccines were not one-hit wonders for mRNA technology.

Full Coverage